KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Long-Term Deferred Tax (2017 - 2025)

Eli Lilly (LLY) has disclosed Long-Term Deferred Tax for 9 consecutive years, with $10.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax rose 24.47% year-over-year to $10.0 billion, compared with a TTM value of $10.0 billion through Dec 2025, up 24.47%, and an annual FY2025 reading of $10.0 billion, up 24.47% over the prior year.
  • Long-Term Deferred Tax was $10.0 billion for Q4 2025 at Eli Lilly, up from $9.0 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $10.0 billion in Q4 2025 and bottomed at $2.4 billion in Q2 2022.
  • Average Long-Term Deferred Tax over 5 years is $5.1 billion, with a median of $4.2 billion recorded in 2023.
  • The sharpest move saw Long-Term Deferred Tax dropped 12.05% in 2021, then skyrocketed 96.12% in 2023.
  • Year by year, Long-Term Deferred Tax stood at $2.5 billion in 2021, then grew by 12.2% to $2.8 billion in 2022, then skyrocketed by 96.12% to $5.5 billion in 2023, then surged by 46.08% to $8.0 billion in 2024, then increased by 24.47% to $10.0 billion in 2025.
  • Business Quant data shows Long-Term Deferred Tax for LLY at $10.0 billion in Q4 2025, $9.0 billion in Q3 2025, and $9.4 billion in Q2 2025.